COXANTO
Live / Registered — Registered (as of 09 May 2023)
What this means for you
Registered since 09 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97162550
- Registration number
- 7050449
- Mark type
- Stylized text
- Filed
- 08 Dec 2021
- Published for opposition
- 25 Oct 2022
- Registered
- 09 May 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical decoctions for the treatment of mild to moderate pain; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Owner
- API2RX, LLC, Madisonville, LA, US
- API2RX, LLC, Madisonville, LA, US
- API2RX, LLC, Madisonville, LA, US
Prosecution history
- 09 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jan 2023 — USE AMENDMENT FILED
- 18 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Oct 2022 — PUBLISHED FOR OPPOSITION
- 05 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Sept 2022 — ASSIGNED TO EXAMINER
- 14 Dec 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED